(MedPage Today) — The combination of vitamin A supplementation and a diet high in omega-3 fatty acids may slow the loss of visual acuity for patients with retinitis pigmentosa, researchers found.
Month: February 2012
New Glaucoma Drug Zioptan Wins FDA Approval
On Friday, the US Food and Drug Administration approved Merck’s Zioptan, a once-daily preservative-free opthalmic solution of tafluprost, a prostaglandin analog for lowering high intra-ocular pressure in patients with open-angle glaucoma or with high…
Technology Lends Product Packaging A Voice To Aid Visually And Hearing Impaired
As the proportion of senior citizens grows, their special needs are gaining momentum. Human eyesight, for example, weakens with age. VTT Technical Research Centre of Finland has been developing new NFC-based applications that make life easier for the v…
Ocular Worries With Candidemia?
iTunes conversion to RSS provided by Feed Flipper: [Web] – [Facebook] – [Donate!]
At what point should you consult with an ophthalmologist when a patient has candidemia? Paul G. Auwaerter, MD, describes a recent study that sheds light on this …
Choose Glaucoma Treatment Based on Risk of Poor Adherence
A new study has found that laser trabeculoplasty and prostaglandin analogs are cost-effective options in managing glaucoma, but trabeculoplasty may be better in patients at risk for poor adherence. Medscape Medical News
New Glaucoma Drug Approved
(MedPage Today) — The FDA has approved an ophthalmic solution of tafluprost (Zioptan), a prostaglandin analog, for patients with open-angle glaucoma, its manufacturer said Monday.
Third patient dosed in Phase 1/2 SMD trial using RPE cells derived from hESCs
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today the dosing of third patient in its Phase 1/2 trial for Stargardt’s macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human e…
Merck’s ZIOPTAN for reducing elevated IOP receives FDA approval
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has approved ZIOPTANTM (tafluprost ophthalmic solution) 0.0015%, the first preservative-free prostaglandin analog ophthalmic solution.
Regeneron reports total revenues of $123.0M for fourth quarter 2011
Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the fourth quarter and full year 2011 and provided an update on development programs.
Comparative Eye Anatomy (ophthalmology)
Comparative Eye Anatomy (ophthalmology)
A video rich examination of the various eyes in the animal kingdom, and what they can teach us about the human eye. The first half of this lecture discuses the progression of ocular complexity from single-cell…
Comparative Eye Anatomy
A review of ocular structures in various animals … starting with the simple light spot of a worm, all the way to the advanced lens-based eye of the human. This is a video and animation rich view of the eye.Cast: Root AtlasTags:
A New Tool in the MS Clinic?
Medscape sits down with Jack N. Ratchford, MD, to discuss potential applications of optical coherence tomography in multiple sclerosis. Medscape Neurology
Genomics pioneer to present at ARVO 2012 meeting
The Association for Research in Vision and Ophthalmology is pleased to welcome J. Craig Venter as the keynote speaker at the opening session of ARVO 2012 on Sunday, May 6 in Fort Lauderdale, Fla. Venter’s presentation is entitled “From Reading to Writi…
Stress Pathway Identified As Potential Therapeutic Target To Prevent Vision Loss
A new study identifies specific cell-stress signaling pathways that link injury of the optic nerve with irreversible vision loss. The research, published by Cell Press in the February 9 issue of the journal Neuron, may lead to new strategies that will …
Successful Gene Therapy For Inherited Blindness
Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their other eye, the patients became better able t…
Suicidal Ideation and Self-Harm in Lesbian, Gay, Bisexual, and Transgender Youth
By: mustanski
Women Suffer More ICD Complications (CME/CE)
(MedPage Today) — Women are at greater risk of complications and are less likely to receive appropriate shocks from their implantable cardioverter-defibrillators than men, researchers found.
Readministration of gene therapy improves vision in three patients with LCA
Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye.
Gene Therapy Proves Effective In Treating Blindness
Researchers from the Perelman School of Medicine at the University of Pennsylvania and The Children’s Hospital of Philadelphia have conducted a recent study, published in Science Translational Medicine which focuses on gene therapy for congenital bli…
Part 2: Stem Cells to be Safe, Too
The recent report of two patients’ vision improving from stem cells is very exciting. Just as exciting is the technology used to do so…safely.